Published in N Engl J Med on May 17, 2007
Consumption of trans-fatty acid and its association with colorectal adenomas. Am J Epidemiol (2008) 1.06
What's law got to do with it Part 2: Legal strategies for healthier nutrition and obesity prevention. Aust New Zealand Health Policy (2008) 0.87
The cardio-protective diet. Indian J Med Res (2010) 0.81
News Media Framing of New York City's Sugar-Sweetened Beverage Portion-Size Cap. Am J Public Health (2015) 0.81
Cities of consumption: the impact of corporate practices on the health of urban populations. J Urban Health (2008) 0.80
Trans-fatty acids, dangerous bonds for health? A background review paper of their use, consumption, health implications and regulation in France. Eur J Nutr (2012) 0.78
Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome. Can J Cardiol (2016) 0.78
trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II. Cancer Causes Control (2009) 0.77
Prospective evaluation of trans-fatty acid intake and colorectal cancer risk in the Iowa Women's Health Study. Int J Cancer (2008) 0.76
Traumatic brain injury in the war zone. N Engl J Med (2005) 5.08
What ails the FDA? N Engl J Med (2005) 3.80
Fighting HIV--lessons from Brazil. N Engl J Med (2006) 1.88
Illness and secrecy on the Supreme Court. N Engl J Med (2004) 1.58
Dr. Pou and the hurricane--implications for patient care during disasters. N Engl J Med (2008) 1.56
Glimpses of Guantanamo--medical ethics and the war on terror. N Engl J Med (2005) 1.50
China and HIV - a window of opportunity. N Engl J Med (2007) 1.47
An elusive balance--residents' work hours and the continuity of care. N Engl J Med (2007) 1.45
Immigrants and health care--at the intersection of two broken systems. N Engl J Med (2007) 1.40
An offshore haven for human embryonic stem-cell research? N Engl J Med (2005) 1.38
Access before approval--a right to take experimental drugs? N Engl J Med (2006) 1.35
Innovation in primary care--staying one step ahead of burnout. N Engl J Med (2008) 1.27
Sex, drugs, prisons, and HIV. N Engl J Med (2007) 1.25
The employer as health coach. N Engl J Med (2007) 1.22
White coat, mood indigo--depression in medical school. N Engl J Med (2005) 1.16
Safety in numbers--monitoring risk in approved drugs. N Engl J Med (2005) 1.08
ADHD in adults. N Engl J Med (2006) 1.01
A to-do list for the new FDA commissioner. N Engl J Med (2009) 1.00
Global health--the Gates-Buffett effect. N Engl J Med (2006) 0.99
Raising the safety bar--the FDA's coxib meeting. N Engl J Med (2005) 0.97
A new attack on malaria. N Engl J Med (2008) 0.94
Medical marijuana and the Supreme Court. N Engl J Med (2005) 0.90
Stem-cell research--signposts and roadblocks. N Engl J Med (2005) 0.90
Betting on a malaria vaccine. N Engl J Med (2005) 0.85
Reconstructing lives--a tale of two soldiers. N Engl J Med (2006) 0.83
Stem-cell politics. N Engl J Med (2006) 0.79
Home delivery--bringing primary care to the housebound elderly. N Engl J Med (2008) 0.77
Facial transplantation: brave new face. N Engl J Med (2006) 0.76
Single-cell storm. N Engl J Med (2006) 0.75
A look at ethics and AIDS -- We're trying to help our sickest people, not exploit them In the researcher's code of conduct, contradictions abound. Washington Post (1997) 0.75
A slow death amid doctor-family conflict. Washington Post (1991) 0.75
XYY: an ethical issue in a genetic riddle. Washington Post (1976) 0.75
Physician-assisted suicide--Oregon and beyond. N Engl J Med (2005) 0.75
U.S. issues child-AIDS guidelines. Washington Post (1985) 0.75